Extreme thinking in clinically depressed adolescents: Results from the Treatment for Adolescents with Depression Study (TADS).

Published

Journal Article

The purpose of this report is to examine relations between extreme thinking, as measured by the Dysfunctional Attitudes Scale, and the maintenance of gains among adolescents who participated in the Treatment for Adolescents with Depression Study (TADS). We examine extreme thinking among 327 adolescents (mean age=14.56, 57% female, 75% White) who received cognitive behavior therapy (CBT), fluoxetine (FLX), or a combination of CBT and FLX (COMB). Among those who met remission status on the Children's Depression Rating Scale - Revised (CDRS-R≤28; 56 at week 12, 79 at week 18) extreme thinking did not predict failure to maintain remission. This is in contrast to findings with depressed adults. Treatment influenced level of extreme thinking, and this appeared to be driven by greater endorsement of positively valenced beliefs as opposed to a decrease in negatively valenced beliefs. Developmental or investigation characteristics may account for the discrepancy in findings.

Full Text

Duke Authors

Cited Authors

  • Jacobs, RH; Reinecke, MA; Gollan, JK; Jordan, N; Silva, SG; March, JS

Published Date

  • November 2010

Published In

Volume / Issue

  • 48 / 11

Start / End Page

  • 1155 - 1159

PubMed ID

  • 20843506

Pubmed Central ID

  • 20843506

Electronic International Standard Serial Number (EISSN)

  • 1873-622X

International Standard Serial Number (ISSN)

  • 0005-7967

Digital Object Identifier (DOI)

  • 10.1016/j.brat.2010.08.001

Language

  • eng